Risk factors for fungal pulmonary infections in hematopoietic stem cell transplantation recipients: The role of iron overload

Bone Marrow Transplantation

Volumn 45, Issue 10, 2010, Pages 1528-1533

  Ozyilmaz, E ^a   Aydogdu, M ^a   Sucak, G ^a   Aki, S Z ^a   Ozkurt, Z N ^a   Yegin, Z A ^a   Kokturk, N ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

fungal pulmonary infections; hematopoietic stem cell transplantation; iron overload; sinusoidal obstruction syndrome

Indexed keywords

FERRITIN;

ADOLESCENT; ADULT; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FIBEROPTIC BRONCHOSCOPY; GRAFT RECIPIENT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INFECTION RISK; IRON OVERLOAD; LIVER VENOOCCLUSIVE DISEASE; LUNG MYCOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICAL RECORD REVIEW; MORTALITY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; THORAX RADIOGRAPHY;

ADOLESCENT; ADULT; AGED; FEMALE; FERRITINS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATIC VENO-OCCLUSIVE DISEASE; HUMANS; IRON OVERLOAD; LUNG DISEASES, FUNGAL; MALE; MEDICAL RECORDS; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TRANSFERRIN; TURKEY; YOUNG ADULT;

EID: 77957936643     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2009.383     Document Type: Article

References (42)

1. Afessa B, Peters SG. Noninfectious pneumonitis after blood and marrow transplant. Curr Opin Oncol 2008; 20: 227-233.
2. Roychowdhury M, Pambuccian SE, Aslan DL, Jessurun J, Rose AG, Manivel JC et al. Pulmonary complications after bone marrow transplantation: an autopsy study from a large transplantation center. Arch Pathol Lab Med 2005; 129: 366-371.
3. Sharma S, Nadrous HF, Peters SG, Tefferi A, Litzow M, Aubry MC et al. Pulmonary complications in adult blood and marrow transplant recipients: autopsy findings. Chest 2005; 128: 1385-1392.
4. Wah TM, Moss HA, Robertson RJH, Barnard DL. Pulmon-ary complications following bone marrow transplantation. Br J Radiol 2003; 76: 373-379.
5. Marr KA, Boeckh M, Martin P, Corey L. Invasive aspergil-losis in allogenic stem cell transplant recipients: changes in epidemiology and risk factors. Blood 2002; 100: 4358-4366.
6. Momin F, Chandrasekar PH. Antimicrobial prophylaxis in bone marrow transplantation. Ann Intern Med 1995; 123: 205-215.
7. Carvalho-Dias VMH, Sola CBS, Cunha CA, Shimakura SE, Pasquini R, Queiroz-Telles F. Invasive aspergillosis in hema-topoietic stem cell transplant recipients: a retrospective analysis. Braz JInfect Dis 2008; 12: 385-389.
8. De La Rosa GR, Champin RE, Kontoyiannis DP. Risk factors for the development of invasive fungal infections in allogenic blood and marrow transplant recipients. Transplant Infect Dis 2002; 4: 3-9.
9. Dvorak CC, Steinbach WJ, Brown JMY, Agarwal R. Risks and outcomes of invasive fungal infections in pediatric patients undergoing allogenic hematopoietic cell transplantation. Bone Marrow Transplant 2005; 36: 621-629.
10. Huisman C, Straaten HM, Canninga-van Dijk MR, Fijnheer R, Verdonck LF. Pulmonary complications after T-cell depleted allogenic stem cell transplantation: low incidence and strong association with acute graft-versus-host disease. Bone Marrow Transplant 2006; 38: 561-566.
11. Bjorklund A, Aschan J, Labopin M, Remberger M, Ringden O, Winiarski J et al. Risk factors for fatal infectious complications developing late after allogenic stem cell trans-plantation. Bone Marrow Transplant 2007; 40: 1055-1062.
12. Yen KT, Lee AS, Krowka MJ, Burger CD. Pulmonary compli-cations in bone marrow transplantation: a practical approach to diagnosis and treatment. Clin Chest Med 2004; 25: 189-201.
13. De Pauw B, Walsh TJ, Donnelly P, Stevens DA, Edwards JE, Calandra T et al. Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Disease 2008; 46: 1813-1821.
14. McDonald GB, Hinds MS, Fisher LD, Schoch HG, Wolford JL, Banaji M et al. Veno-occlusive disease of the liver and mutiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med 1993; 118: 255.
15. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995; 15: 825-828.
16. Jantunen E, Ruutu P, Niskanen L, Volin L, Parkkali T, Koukila-Kahkola P et al. Incidence and risk factors for invasive fungal infections in allogenic BMT recipients. Bone Marrow Transplant 1997; 19: 801-808.
17. Dunagan DP, Baker AM, Hurd DD, Haponik EF. Broncho-scopic evaluation of pulmonary infiltrates following bone marrow transplantation. Chest 1997; 111: 135-141.
18. Hofmeister CC, Czerlanis C, Forsythe S, Stiff PJ. Retro-spective utility of bronchoscopy after hematopoietic stem cell transplant. Bone Marrow Transplant 2006; 38: 693-698.
19. Thursky K, Byrnes G, Grigg A, Szer J, Slavin M. Risk factors for post-engraftment invasive aspergillosis in allogenic stem cell transplantation. Bone Marrow Transplant 2004; 34: 115-121.
20. Mikulska M, Raiola AM, Bruno B, Furfaro E, Van Lint MT, Bregante S et al. Risk factors for invasive aspergillosis and related mortality in recipients of allogenic SCT from alter-native donors: an analysis of 306 patients. Bone Marrow Transplant 2009; 44: 361-370.
21. Meyers JD, Atkinson K. Infection in bone marrow transplan-tation. Clin Hematol 1983; 12: 791-811.
22. Andrews NC Disorders of iron metabolism. N Engl J Med 1999; 341: 1986-1995.
23. Majhail NS, Lazarus HM, Burns LJ. Iron overload in hematopoietic cell transplantation. Bone Marrow Transplant 2008; 41: 997-1003.
24. Sahlstedt L, Ebeling F, von Bonsdorff L, Parkkinen J, Ruutu T. Non-transferrin bound iron during allogenic stem cell transplantation. Br J Haematol 2001; 113: 836-838.
25. Kontoghiorghes GJ, Weinberg ED. Iron: mammalian defense systems, mechanisms of disease, and chelation therapy approaches. Blood Rev 1995; 9: 33-45.
26. Van Asbeck BS, Marx JJ, Struyvenberg A, Verhoef J. Functional defects in phagocytic cells from patients with iron overload. JInfect 1984; 8: 232-240.
27. Hissen AH, Wan AN, Warwas MI, Pinto LJ, Moore MM. The aspergillus fumigatus siderophore biosynthetic gene sidA, encoding L-ornithine N5-oxygenase is required for virulence. Infect Immun 2005; 73: 5493-5503.
28. Maertens J, Demuynck H, Verbeken EK, Zachee P, Verhoef GEG, Vandenberghe P et al. Mucormycosis in allogenic bone marrow transplant recipients: report offive cases and review of the role of iron overload in the pathogenesis. Bone Marrow Transplant 1999; 24: 307-312.
29. Altes A, Remacha AF, Sarda P, Sancho FJ, Sureda A, Martino R et al. Frequent severe iron overload after stem cell transplantation and its possible association with invasive aspergillosis. Bone Marrow Transplant 2004; 34: 505-509.
30. Kontoyiannis DP, Chamilos G, Lewis RE, Giralt S, Cortes J, Raad II et al. Increased bone marrow iron stores is an independent risk factor for invasive aspergillosis in patients with high risk hematologic malignancies and recipients of allogenic hematopoietic stem cell transplantation. Cancer 2007; 110: 1303-1306.
31. Durken M, Nielsen P, Knobel S, Finckh B, Hernring C, Dresow B et al. Nontransferrin-bound iron in serum of patients receiving bone marrow transplants. Free Radic Biol Med 1997; 22: 1159-1163.
32. Gordon LI, Brown SG, Tallman MS, Rademaker AW, Weitzman SA, Lazarus HM et al. Sequential changes in serum iron and ferritin in patients undergoing high-dose chemother-apy and radiation with autologous bone marrow transplant-ation: possible implications for treatment related toxicity. Free Radic Biol Med 1995; 18: 383-389.
33. Sahlstedt L, Ebeling F, von Bonsdorff L, Parkkinen J, Ruutu T. Non-transferrin-bound iron during allogeneic stem cell transplantation. Br J Haematol 2001; 113: 836-838.
34. Armand P, Kim HT, Cutler CS, Ho VT, Koreth J, Alyes EP et al. Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell trans-plantation. Blood 2007; 109: 4586-4588.
35. Rosetti F, Brawner DL, Bowden R, Meyer WG, Schoch HG, Fisher L et al. Fungal liver infection in marrow transplant recipients: prevalence at autopsy, predisposing factors, and clinical features. Clin Infect Dis 1995; 20: 801-811.
36. Morado M, Ojeda E, Garcia-Bustos J, Aguado MJ, Arrieta R, Quevedo E et al. BMT: serum ferritin as a risk factor for veno-occlusive disease of the liver. Prospective cohort study. Hematology 2000; 4: 505-512.
37. Maradei SC, Maiolino A, Azevedo AM, Colares M, Bouzas LF, Nucci M. Serum ferritin as risk factor of sinusoidal obstruction syndrome of the liver in patients undergoing hematopoietic stem cell transplantation. Blood 2009; 114: 1270-1275.
38. Sucak GT, Aki ZS, Yagci M, Yegin ZA, Ozkurt ZN, Haznedar R. Treatment of sinusoidal obstruction syndrome with defibrotide: a single center experience. Transplant Proc 2007; 39: 1558-1563.
39. Qureshi A, Marshall L, Lancester D. Defibrotide in the prevention and treatment of veno-occlusive disease in auto-logous and allogenic stem cell transplantation in children. Pediatr Blood Cancer 2008; 50: 831-832.
40. Dignan F, Gujral D, Ethell M, Evans S, Treleaven J, Morgan G et al. Prophylactic defibrotide in allogeneic stem cell transplantation: minimal morbidity and zero mortality from veno-occlusive disease. Bone Marrow Transplant 2007; 40: 79-82.
41. Aki ZS, Sucak GT, Yegin ZA, Guzel O, Erbas G, Senol E. Hematopoietic stem cell transplantation in patients with active fungal infection: not a contraindication for transplantation. Transplant Proc 2008; 40: 1579-1585.
42. Zhang P, Song A, Wang Z, Feng S, Qui L, Han M. Hematopoietic SCT in patients with a history of invasive fungal infection. Bone Marrow Transplant 2009; 43: 533-537.